The biodegradable stents are used for treating cardiovascular conditions pertaining to the coronary artery. These stents are also known as bioabsorbable or bioresorbable vascular scaffolds and are surgically placed in the coronary artery for eluting the drug that is administered for vascular restoration and the polymer coating. The biggest advantage of these stents is that they get entirely absorbed in the vessels over a period of time, reducing the risk of complications or infections.
This report contains market size and forecasts of Biodegradable Stents in global, including the following market information:
- Global Biodegradable Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Biodegradable Stents Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biodegradable Stents companies in 2021 (%)
The global Biodegradable Stents market was valued at 726.1 million in 2021 and is projected to reach US$ 2854 million by 2028, at a CAGR of 21.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Polymer Based Bioabsorbable Stents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biodegradable Stents include Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Xenogenics Corporation and Meril Life Sciences Pvt. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biodegradable Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biodegradable Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biodegradable Stents Market Segment Percentages, by Type, 2021 (%)
Polymer Based Bioabsorbable Stents
Metal Based Bioabsorbable Stents
Global Biodegradable Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biodegradable Stents Market Segment Percentages, by Application, 2021 (%)
Coronary Artery Disease
Peripheral Artery Disease
Global Biodegradable Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biodegradable Stents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biodegradable Stents revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biodegradable Stents revenues share in global market, 2021 (%)
Key companies Biodegradable Stents sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biodegradable Stents sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Kyoto Medical Planning
Reva Medical
Elixir Medical Corporation
Amaranth Medical
Terumo Corporation
Arterius Limited
Biotronik, Xenogenics Corporation
Meril Life Sciences Pvt
